DECISION OF THE EEA JOINT COMMITTEE

No 29/2017

of 3 February 2017

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/1763]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2016/1929 of 4 November 2016 approving Bacillus thuringiensis subsp. kurstaki, serotype 3a3b, strain ABTS-351, as an active substance for use in biocidal products of product-type 18 (1) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Regulation (EU) 2016/1930 of 4 November 2016 approving chlorocresol as an existing active substance for use in biocidal products of product-types 1, 2, 3, 6 and 9 (2) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Regulation (EU) 2016/1931 of 4 November 2016 approving chlorocresol as an existing active substance for use in biocidal products of product-type 13 (3) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Regulation (EU) 2016/1932 of 4 November 2016 approving calcium magnesium oxide (burnt dolomitic lime) as an existing active substance for use in biocidal products of product-types 2 and 3 (4) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Regulation (EU) 2016/1933 of 4 November 2016 approving calcium magnesium tetrahydroxide (hydrated dolomitic lime) as an existing active substance for use in biocidal products of product-types 2 and 3 (5) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Regulation (EU) 2016/1934 of 4 November 2016 approving coco alkyltrimethylammonium chloride (ATMAC/TMAC) as an existing active substance for use in biocidal products of product-type 8 (6) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Regulation (EU) 2016/1935 of 4 November 2016 approving calcium dihydroxide (hydrated lime) as an existing active substance for use in biocidal products of product-types 2 and 3 (7) is to be incorporated into the EEA Agreement.

(8) Commission Implementing Regulation (EU) 2016/1937 of 4 November 2016 approving cyfluthrin as an existing active substance for use in biocidal products of product-type 18 (8) is to be incorporated into the EEA Agreement.

(9) Commission Implementing Regulation (EU) 2016/1938 of 4 November 2016 approving citric acid as an existing active substance for use in biocidal products of product-type 2 (9) is to be incorporated into the EEA Agreement.

(10) Commission Implementing Decision (EU) 2016/1943 of 4 November 2016 pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on the use of paraffin oil for coating eggs to control the population size of nesting birds (10) is to be incorporated into the EEA Agreement.

(11) Commission Implementing Decision (EU) 2016/1950 of 4 November 2016 on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (11) is to be incorporated into the EEA Agreement.

(12) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 2 The texts of Implementing Regulations (EU) 2016/1929, (EU) 2016/1930, (EU) 2016/1931, (EU) 2016/1932, (EU) 2016/1933, (EU) 2016/1934, (EU) 2016/1935, (EU) 2016/1937 and (EU) 2016/1938 and Implementing Decisions (EU) 2016/1943 and (EU) 2016/1950 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3 This Decision shall enter into force on 4 February 2017, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4 This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 3 February 2017. For the EEA Joint Committee The President Claude MAERTEN

(1) OJ L 299, 5.11.2016, p. 26.

(2) OJ L 299, 5.11.2016, p. 29.

(3) OJ L 299, 5.11.2016, p. 33.

(4) OJ L 299, 5.11.2016, p. 36.

(5) OJ L 299, 5.11.2016, p. 39.

(6) OJ L 299, 5.11.2016, p. 42.

(7) OJ L 299, 5.11.2016, p. 45.

(8) OJ L 299, 5.11.2016, p. 51.

(9) OJ L 299, 5.11.2016, p. 54.

(10) OJ L 299, 5.11.2016, p. 90.

(11) OJ L 300, 8.11.2016, p. 14.

(*1) No constitutional requirements indicated.